GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Tabula Rasa HealthCare Inc (NAS:TRHC) » Definitions » EV-to-EBIT

Tabula Rasa HealthCare (Tabula Rasa HealthCare) EV-to-EBIT : -10.31 (As of May. 05, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Tabula Rasa HealthCare EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Tabula Rasa HealthCare's Enterprise Value is $557.6 Mil. Tabula Rasa HealthCare's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $-54.1 Mil. Therefore, Tabula Rasa HealthCare's EV-to-EBIT for today is -10.31.

The historical rank and industry rank for Tabula Rasa HealthCare's EV-to-EBIT or its related term are showing as below:

TRHC' s EV-to-EBIT Range Over the Past 10 Years
Min: -540.2   Med: -29.03   Max: 187.45
Current: -10.31

During the past 10 years, the highest EV-to-EBIT of Tabula Rasa HealthCare was 187.45. The lowest was -540.20. And the median was -29.03.

TRHC's EV-to-EBIT is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 18.53 vs TRHC: -10.31

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Tabula Rasa HealthCare's Enterprise Value for the quarter that ended in Jun. 2023 was $496.8 Mil. Tabula Rasa HealthCare's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $-54.1 Mil. Tabula Rasa HealthCare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -10.89%.


Tabula Rasa HealthCare EV-to-EBIT Historical Data

The historical data trend for Tabula Rasa HealthCare's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tabula Rasa HealthCare EV-to-EBIT Chart

Tabula Rasa HealthCare Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.87 -39.69 -31.47 -17.39 -5.90

Tabula Rasa HealthCare Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.02 -6.23 -5.90 -7.52 -9.19

Competitive Comparison of Tabula Rasa HealthCare's EV-to-EBIT

For the Health Information Services subindustry, Tabula Rasa HealthCare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tabula Rasa HealthCare's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Tabula Rasa HealthCare's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Tabula Rasa HealthCare's EV-to-EBIT falls into.



Tabula Rasa HealthCare EV-to-EBIT Calculation

Tabula Rasa HealthCare's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=557.619/-54.086
=-10.31

Tabula Rasa HealthCare's current Enterprise Value is $557.6 Mil.
Tabula Rasa HealthCare's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-54.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tabula Rasa HealthCare  (NAS:TRHC) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Tabula Rasa HealthCare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2023 ) =EBIT / Enterprise Value (Q: Jun. 2023 )
=-54.086/496.8168
=-10.89 %

Tabula Rasa HealthCare's Enterprise Value for the quarter that ended in Jun. 2023 was $496.8 Mil.
Tabula Rasa HealthCare's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-54.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tabula Rasa HealthCare EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Tabula Rasa HealthCare's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Tabula Rasa HealthCare (Tabula Rasa HealthCare) Business Description

Traded in Other Exchanges
N/A
Address
228 Strawbridge Drive, Suite 100, Moorestown, NJ, USA, 08057
Tabula Rasa HealthCare Inc is engaged in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The cloud-based software solutions of the company help prescribers, pharmacists, and healthcare organizations in managing the medication-related needs of patients. The firm operates the business through two segments namely CareVention HealthCare and MedWise HealthCare.
Executives
Michael Anthony Bruno officer: CHIEF ACCOUNTING OFFICER 1504 PEAR TREE LANE, BENSALEM PA 19020
Derek C Schrier director, 10 percent owner C/O INDABA CAPITAL MANAGEMENT, LLC, ONE LETTERMAN DR., BLDING D, SUITE DM700, SAN FRANCISCO CA 94129
Indaba Capital Fund, L.p. director, 10 percent owner MAPLES CORPORATE SERVICES, 121 SOUTH CHURCH STREET, GRAND CAYMAN E9 KY1-1104
Indaba Capital Management, L.p. director, 10 percent owner ONE LETTERMAN DRIVE, BUILDING D, SUITE DM700, SAN FRANCISCO CA 94129
Ic Gp, Llc director, 10 percent owner ONE LETTERMAN DRIVE,, BUILDING D, SUITE DM700, SAN FRANCISCO CA 94129
Rew Richard W. Ii officer: Chief Legal Officer, Secretary 7000 WEST WILLIAM CANNON, BUILDING ONE, AUSTIN TX 78735
Thomas Cancro officer: CHIEF FINANCIAL OFFICER C/O GFI GROUP INC., NEW YORK NY 10041
Michael J. Purcell director C/O PATRIOT NATIONAL, INC., 401 E. LAS OLAS BLVD., SUITE 1650, FORT LAUDERDALE FL 33301
Ronald Paul Mitchell director 110 W. KINZIE STREET, 5TH FL, CHICAGO IL 60654
Jonathan David Schwartz director 430 EAST 29TH STREET, SUITE 1040, NEW YORK NY 10016
Dennis Helling director 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057
Michael Greenhalgh officer: Chief Operating Officer 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057
Gordon Tunstall director
Andrea Carolan Speers officer: Chief Accounting Officer 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057
Brian W Adams officer: Chief Financial Officer 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057